- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 6, 2025 | 36.5M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $227.78M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $248.48M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $9.38M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $8.77M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $16.22M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $9.51M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $290.97M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $309.8M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $302.05M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $314.93M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $56.81M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $74.27M |
| Net Income | Q1 2025 · Dec 31, 2024 | −$78.3M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$22.67M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 2.05M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1.07M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$17.62M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$39.63M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$25.63M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$11.07 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$11.07 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $12.5M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$17.09M |